mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.11 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |